TrialCancer science2020

Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101.

Motohide Uemura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.